A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 24,500 shares of FLGT stock, worth $476,035. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,500
Holding current value
$476,035
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$19.09 - $22.57 $467,705 - $552,965
24,500 New
24,500 $480,000
Q3 2020

Nov 16, 2020

SELL
$15.89 - $50.51 $177,968 - $565,712
-11,200 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$8.89 - $18.28 $36,449 - $74,948
-4,100 Reduced 26.8%
11,200 $179,000
Q1 2020

May 15, 2020

SELL
$6.75 - $19.75 $118,800 - $347,600
-17,600 Reduced 53.5%
15,300 $165,000
Q4 2019

Feb 14, 2020

BUY
$9.29 - $15.82 $305,641 - $520,478
32,900 New
32,900 $424,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $588M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.